Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-02 20:44 | 2022-10-20 | N-A | N/A | BLACKROCK FINANCIAL MANAGEMENT INC/DE | 10% owner | Other | BUY | $23.74 | 1,255,265 | $29,799,991 | 4,106,691 | +44.0% |
| 2022-11-01 23:30 | 2022-10-28 | N/A | N/A | Pension Fund for State Employees | 10% owner | Other | BUY | $9.57 | 313,479 | $2,999,994 | 813,479 | +62.7% |
| 2022-11-01 22:50 | 2022-10-31 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $15.81 | 88,544 | $1,400,003 | 8,745,577 | +1.0% |
| 2022-11-01 22:36 | 2022-10-31 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $15.81 | 126,492 | $2,000,004 | 6,342,895 | +2.0% |
| 2022-11-01 22:24 | 2022-10-31 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $15.81 | 126,492 | $2,000,004 | 5,222,642 | +2.5% |
| 2022-11-01 15:00 | 2022-11-01 | SRLP | N/A | Sprague HP Holdings LLC | 10% owner, Other | Other | BUY | $20.00 | 6,689,383 | $133,787,660 | 19,548,849 | +52.0% |
| 2022-11-01 22:44 | 2022-10-28 | KO | COCA COLA CO | Allen Herbert A III | Director | Beverages | BUY | $60.18 | 33,200 | $1,997,953 | 99,054 | +50.4% |
| 2022-10-31 14:52 | 2022-10-28 | BHVN | Biohaven Ltd. | Coric Vlad | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $14.84 | 141,930 | $2,105,773 | 109,565 | +100.0% |
| 2022-10-31 19:12 | 2022-10-28 | TXMD | TherapeuticsMD, Inc. | Rubric Capital Management LP | 10% owner | Pharmaceutical Preparations | BUY | $1,000.00 | 7,000 | $7,000,000 | 29,000 | +31.8% |
| 2022-11-01 01:00 | 2022-10-28 | MBLY | Mobileye Global Inc. | Shashua Amnon | Director, Officer - CEO and President | Services-Prepackaged Software | BUY | $21.00 | 476,191 | $10,000,011 | 476,191 | +100.0% |
| 2022-11-01 01:02 | 2022-10-28 | MBLY | Mobileye Global Inc. | Pambianchi Christine M | Director | Services-Prepackaged Software | BUY | $21.00 | 70,000 | $1,470,000 | 70,000 | +100.0% |
| 2022-10-31 23:15 | 2022-10-28 | ALLE | Allegion plc | Stone John H | Director, Officer - President and CEO | Services-Detective, Guard & Armored Car Services | BUY | $104.45 | 12,500 | $1,305,613 | 64,535 | +24.0% |
| 2022-10-31 20:17 | 2022-10-27 | EMO | ClearBridge Energy Midstream Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% owner | Other | BUY | $29.56 | 53,548 | $1,583,104 | 1,604,304 | +3.5% |
| 2022-11-01 01:07 | 2022-10-28 | MBLY | Mobileye Global Inc. | GELSINGER PATRICK P | Director | Services-Prepackaged Software | BUY | $21.00 | 120,000 | $2,520,000 | 120,000 | +100.0% |
| 2022-10-28 21:57 | 2022-10-26 | EPIX | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $4.11 | 2,000,000 | $8,219,600 | 7,879,583 | +34.0% |
| 2022-10-29 01:09 | 2022-10-28 | BECN | N/A | CD&R Investment Associates IX, Ltd. | 10% owner | Other | BUY | $56.97 | 105,320 | $5,999,943 | 14,964,899 | +0.7% |
| 2022-10-29 00:00 | 2022-10-26 | N-A | N/A | ANGELO GORDON & CO., L.P. | 10% owner | Other | BUY | $25.55 | 2,064,386 | $52,740,942 | 8,902,079 | +30.2% |
| 2022-10-28 00:27 | 2022-10-26 | N/A | N/A | UAW Chrysler Retireees Medical Benefits Plan | 10% owner | Other | BUY | $9.79 | 7,079,359 | $69,306,925 | 15,493,296 | +84.1% |
| 2022-10-27 18:05 | 2022-10-25 | EMO | ClearBridge Energy Midstream Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% owner | Other | BUY | $28.77 | 44,255 | $1,273,053 | 1,550,756 | +2.9% |
| 2022-10-27 23:36 | 2022-10-25 | SRRK | Scholar Rock Holding Corp | Invus Public Equities, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $8.04 | 130,265 | $1,047,383 | 8,980,270 | +1.5% |
| 2022-10-27 01:21 | 2022-10-25 | BHVN | Biohaven Ltd. | Buten Matthew | Officer - Chief Financial Officer | Pharmaceutical Preparations | BUY | $10.50 | 142,857 | $1,499,999 | 166,653 | +600.3% |
| 2022-10-27 03:00 | 2022-10-24 | PRME | Prime Medicine, Inc. | Cahill Thomas | Director | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 400,000 | $6,800,000 | 5,305,679 | +8.2% |
| 2022-10-27 01:22 | 2022-10-25 | BHVN | Biohaven Ltd. | Coric Vlad | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $10.50 | 853,380 | $8,960,490 | 1,475,664 | +137.1% |
| 2022-10-27 03:02 | 2022-10-24 | PRME | Prime Medicine, Inc. | GV 2019 GP, L.L.C. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 800,000 | $13,600,000 | 11,522,248 | +7.5% |
| 2022-10-27 01:22 | 2022-10-25 | BHVN | Biohaven Ltd. | Bailey Gregory | Director | Pharmaceutical Preparations | BUY | $10.50 | 200,000 | $2,100,000 | 1,507,971 | +15.3% |
| 2022-10-27 03:01 | 2022-10-24 | PRME | Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 800,000 | $13,600,000 | 6,128,297 | +15.0% |
| 2022-10-27 03:01 | 2022-10-24 | PRME | Prime Medicine, Inc. | ARCH Venture Partners X, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 800,000 | $13,600,000 | 6,128,297 | +15.0% |
| 2022-10-27 01:22 | 2022-10-25 | BHVN | Biohaven Ltd. | CHILDS JOHN W | Director | Pharmaceutical Preparations | BUY | $10.50 | 3,900,000 | $40,950,000 | 5,691,251 | +217.7% |
| 2022-10-27 01:43 | 2022-10-24 | LNDC | LIFECORE BIOMEDICAL, INC. DE | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10% owner | Pharmaceutical Preparations | BUY | $8.09 | 250,000 | $2,022,500 | 2,155,694 | +13.1% |
| 2022-10-26 00:14 | 2022-10-21 | LOCL | Local Bounti Corporation/DE | Schwab Charles R. | 10% owner | Agricultural Production-Crops | BUY | $2.50 | 3,000,000 | $7,500,000 | 11,157,694 | +36.8% |
| 2022-10-25 23:19 | 2022-10-21 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% owner | Pharmaceutical Preparations | BUY | $4.50 | 500,000 | $2,247,600 | 8,229,963 | +6.5% |
| 2022-10-25 04:49 | 2022-10-20 | FBK | FB Financial Corp | Ayers James W. | 10% owner, Other | State Commercial Banks | BUY | $37.25 | 53,088 | $1,977,528 | 10,704,991 | +0.5% |
| 2022-10-24 19:56 | - | COSM | Cosmos Health Inc. | Siokas Grigorios | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $0.12 | 12,500,000 | $1,500,000 | 19,334,168 | +182.9% |
| 2022-10-21 23:12 | 2022-10-19 | N/A | N/A | UAW Chrysler Retireees Medical Benefits Plan | 10% owner | Other | BUY | $994.97 | 29,850 | $29,699,775 | 131,137 | +29.5% |
| 2022-10-22 01:03 | 2022-10-20 | EVA | N/A | UBBEN JEFFREY W | Director | Other | BUY | $50.25 | 25,000 | $1,256,125 | 5,513,742 | +0.5% |
| 2022-10-21 22:03 | 2022-10-19 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% owner | Pharmaceutical Preparations | BUY | $3.89 | 454,399 | $1,767,476 | 7,729,963 | +6.2% |
| 2022-10-21 00:25 | 2022-10-18 | TCDA | N/A | Venrock Healthcare Capital Partners II, L.P. | 10% owner | Other | BUY | $10.68 | 351,866 | $3,756,275 | 10,202,946 | +3.6% |
| 2022-10-21 00:28 | 2022-10-18 | ETNB | N/A | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Other | BUY | $7.65 | 1,172,741 | $8,971,469 | 8,955,410 | +15.1% |
| 2022-10-21 00:24 | 2022-10-17 | GRX-C | Gabelli Healthcare & WellnessRx Trust | GABELLI MARIO J | Director, 10% owner, Other | Other | BUY | $20.00 | 50,000 | $1,000,000 | 175,000 | +40.0% |
| 2022-10-19 23:40 | 2022-10-17 | IMRA | Enliven Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $3.68 | 506,197 | $1,860,983 | 3,134,923 | +19.3% |
| 2022-10-19 23:32 | 2022-10-17 | DICE | N/A | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Other | BUY | $36.50 | 1,640,000 | $59,860,000 | 6,848,911 | +31.5% |
| 2022-10-20 04:55 | 2022-10-17 | VEII | Value Exchange International, Inc. | Chan Heng Fai Ambrose | Director, 10% owner | Services-Miscellaneous Business Services | BUY | $0.24 | 7,276,163 | $1,744,096 | 13,776,163 | +111.9% |
| 2022-10-20 01:28 | 2022-10-17 | GRX-E | Gabelli Healthcare & WellnessRx Trust | GABELLI MARIO J | Director, 10% owner, Other | Other | BUY | $10.00 | 230,000 | $2,300,000 | 700,000 | +48.9% |
| 2022-10-19 23:24 | 2022-10-17 | GDL-E | GDL FUND | GABELLI MARIO J | Director, 10% owner, Other | Other | BUY | $10.00 | 200,000 | $2,000,000 | 500,000 | +66.7% |
| 2022-10-18 20:23 | 2022-10-14 | N/A | N/A | UAW Chrysler Retireees Medical Benefits Plan | 10% owner | Other | BUY | $5,068.00 | 4,884 | $24,749,999 | 7,738 | +171.1% |
| 2022-10-18 16:23 | 2022-10-14 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $15.75 | 507,866 | $8,000,003 | 8,656,608 | +6.2% |
| 2022-10-18 16:11 | 2022-10-14 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $15.75 | 380,899 | $6,000,002 | 6,216,084 | +6.5% |
| 2022-10-18 15:52 | 2022-10-14 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $15.75 | 253,933 | $4,000,002 | 5,095,938 | +5.2% |
| 2022-10-19 02:58 | 2022-10-17 | GGZ-B | Gabelli Global Small & Mid Cap Value Trust | GABELLI MARIO J | Director, 10% owner, Other | Other | BUY | $10.00 | 158,554 | $1,585,540 | 288,174 | +122.3% |
| 2022-10-18 23:35 | 2022-10-14 | N-A | N/A | ANGELO GORDON & CO., L.P. | 10% owner | Other | BUY | $25.48 | 1,719,855 | $43,821,900 | 6,870,534 | +33.4% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.